Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 352 Neoplasm Metastasis 31 Stomach Neoplasms 30 HER2-positive Breast Cancer 19 Neoplasms 16 Breast Neoplasms, Male 16 Brain Neoplasms 13 Inflammatory Breast Neoplasms 12 Esophageal Neoplasms 10 Colorectal Neoplasms 10 Triple Negative Breast Neoplasms 8 Adenocarcinoma 7 Prostatic Neoplasms 6 Cardiotoxicity 6 Carcinoma, Non-Small-Cell Lung 6 Ovarian Neoplasms 5 Lung Neoplasms 5 Carcinoma, Ductal, Breast 5 Biliary Tract Neoplasms 5 Salivary Gland Neoplasms 4 Pathologic Complete Response 4 Pancreatic Neoplasms 4 Meningeal Neoplasms 4 Colonic Neoplasms 4 Breast Diseases 4 Recurrence 3 Rectal Neoplasms 3 Meningeal Carcinomatosis 3 Gallbladder Neoplasms 3 Carcinoma, Lobular 3

Interventions

Echocardiography 4 sacubitril and valsartan sodium hydrate drug combination 3 Standard of Care 3 Nutrition Assessment 3 Exercise 3 Electrocardiography 3 Carvedilol 3 dapagliflozin 2 Surveys and Questionnaires 2 Spironolactone 2 Ivabradine 2 Blood Specimen Collection 2 Atorvastatin 2 ziprasidone 1 pertuzumab 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 empagliflozin 1 candesartan 1 Zolpidem 1 Watchful Waiting 1 Warfarin 1 Vincristine 1 Vecuronium Bromide 1 Vascular Stiffness 1 Vancomycin 1 Valsartan 1 Trastuzumab 1 Tranexamic Acid 1 Tobramycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Heart Failure × Trastuzumab × Clear all

NCT04680442 2025-04-06

SCHOLAR-2

Population Health Research Institute

Phase 2 Recruiting

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡